Hibiwash 500ml
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 2 recall · DMRC- 38814497
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Hibiwash 500ml | PL: 22099/0003 | chlorhexidine gluconate 4% | 07333350300401 |
Batches (expiry): 5156042 (28/11/2028), 500ml (10/02/2026), 5156043 (28/11/2028), 5156093 (28/11/2028), 500ml (10/03/2026)
Background: Mölnlycke Health Care are recalling specific batches of Hibiwash due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring. The microbial contamination has been identified as Burkholderia cepacia. The investigation is ongoing, and to date no Hibiwash products have been found to be contaminated, however the batches at risk of contamination are being recalled as a precaution to mitigate any risks to public health. Burkolderia cepacia is a gram-negative bacteria that is widely found in the environment, including soil and water, and has intrinsic resistance to many antibiotics. The risk to the general public from Burkholderia cepacia is considered very low, but some patient groups (such as individuals with cystic fibrosis or awaiting lung transplant) are at potentially increased risk of developing infections. The use of the batches